The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Cyclophosphamide dose: how much is needed to win the war against paraquat poisoning?

  • Sun, In O (Division of Nephrology and Toxicology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Lee, Kwang Young (Division of Nephrology and Toxicology, Department of Internal Medicine, Presbyterian Medical Center)
  • Published : 2013.07.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Dinis-Oliveira RJ, Duarte JA, Sanchez-Navarro A, Remiao F, Bastos ML, Carvalho F. Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment. Crit Rev Toxicol 2008;38:13-71. https://doi.org/10.1080/10408440701669959
  2. Gawarammana IB, Buckley NA. Medical management of paraquat ingestion. Br J Clin Pharmacol 2011;72:745-757. https://doi.org/10.1111/j.1365-2125.2011.04026.x
  3. Senarathna L, Eddleston M, Wilks MF, et al. Prediction of outcome after paraquat poisoning by measurement of the plasma paraquat concentration. QJM 2009;102:251-259. https://doi.org/10.1093/qjmed/hcp006
  4. Xiangdong J, Ming L, Yijing Z, et al. Role of growth factors in acute lung injury induced by paraquat in a rat model. Hum Exp Toxicol 2011;30:460-469. https://doi.org/10.1177/0960327110372648
  5. Proudfoot AT, Stewart MS, Levitt T, Widdop B. Paraquat poisoning: Significance of plasma-paraquat concentrations. Lancet 1979;2:330-332.
  6. Hart TB, Nevitt A, Whitenhead A. A new statistical approach to the prognostic significance of plasma paraquat concentrations. Lancet 1984;2:1222-1223.
  7. Sawada Y, Yamamoto I, Hirokane T, Nagai Y, Satoh Y, Ueyama M. Severity index of paraquat poisoning. Lancet 1988;1:1333.
  8. Huang NC, Lin SL, Hung YM, Hung SY, Chung HM. Severity assessment in acute paraquat poisoning by analysis of APACHE II score. J Formos Med Assoc 2003;102:782-787.
  9. Yeo CD, Kim JW, Kim YO, Yoon SA, Kim KH, Kim YS. The role of pentraxin-3 as a prognostic biomarker in paraquat poisoning. Toxicol Lett 2012;212:157-160. https://doi.org/10.1016/j.toxlet.2011.12.007
  10. Gil HW, Yang JO, Lee EY, Hong SY. Clinical implication of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 in patients with acute paraquat intoxication. Clin Toxicol (Phila) 2009;47:870-875. https://doi.org/10.3109/15563650903306651
  11. Gould VE, Miller J. Sclerosing alveolitis induced by cyclophosphamide: ultrastructural observations on alveolar injury and repair. Am J Pathol 1975;81:513-530.
  12. Choi JS, Jou SS, Oh MH, et al. The dose of cyclophosphamide for treating paraquat-induced rat lung injury. Korean J Intern Med 2013;28:420-427. https://doi.org/10.3904/kjim.2013.28.4.420
  13. Seifirad S, Keshavarz A, Taslimi S, Aran S, Abbasi H, Ghaffari A. Effect of pirfenidone on pulmonary fibrosis due to paraquat poisoning in rats. Clin Toxicol (Phila) 2012;50:754-758. https://doi.org/10.3109/15563650.2012.718783

Cited by

  1. Inhibition of connective tissue growth factor attenuates paraquat‐induced lung fibrosis in a human MRC‐5 cell line vol.31, pp.11, 2013, https://doi.org/10.1002/tox.22166
  2. Predictive values of urine paraquat concentration, dose of poison, arterial blood lactate and APACHE II score in the prognosis of patients with acute paraquat poisoning vol.14, pp.1, 2017, https://doi.org/10.3892/etm.2017.4463
  3. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning vol.47, pp.2, 2019, https://doi.org/10.1177/0300060518806110